全文获取类型
收费全文 | 134924篇 |
免费 | 31657篇 |
国内免费 | 1197篇 |
专业分类
耳鼻咽喉 | 2814篇 |
儿科学 | 3820篇 |
妇产科学 | 3349篇 |
基础医学 | 7771篇 |
口腔科学 | 5445篇 |
临床医学 | 31397篇 |
内科学 | 31430篇 |
皮肤病学 | 3899篇 |
神经病学 | 15962篇 |
特种医学 | 4244篇 |
外国民族医学 | 1篇 |
外科学 | 20572篇 |
综合类 | 854篇 |
现状与发展 | 40篇 |
一般理论 | 42篇 |
预防医学 | 17806篇 |
眼科学 | 2919篇 |
药学 | 3765篇 |
中国医学 | 84篇 |
肿瘤学 | 11564篇 |
出版年
2024年 | 749篇 |
2023年 | 5177篇 |
2022年 | 1495篇 |
2021年 | 3442篇 |
2020年 | 5671篇 |
2019年 | 2670篇 |
2018年 | 7586篇 |
2017年 | 7860篇 |
2016年 | 8524篇 |
2015年 | 8751篇 |
2014年 | 11421篇 |
2013年 | 13706篇 |
2012年 | 6328篇 |
2011年 | 6238篇 |
2010年 | 8128篇 |
2009年 | 10334篇 |
2008年 | 5935篇 |
2007年 | 5107篇 |
2006年 | 6365篇 |
2005年 | 4880篇 |
2004年 | 4221篇 |
2003年 | 3743篇 |
2002年 | 3466篇 |
2001年 | 2131篇 |
2000年 | 1366篇 |
1999年 | 1992篇 |
1998年 | 2485篇 |
1997年 | 2265篇 |
1996年 | 2260篇 |
1995年 | 2000篇 |
1994年 | 1319篇 |
1993年 | 1175篇 |
1992年 | 925篇 |
1991年 | 813篇 |
1990年 | 672篇 |
1989年 | 668篇 |
1988年 | 676篇 |
1987年 | 515篇 |
1986年 | 466篇 |
1985年 | 428篇 |
1984年 | 432篇 |
1983年 | 471篇 |
1982年 | 453篇 |
1981年 | 365篇 |
1980年 | 298篇 |
1979年 | 169篇 |
1978年 | 225篇 |
1977年 | 226篇 |
1976年 | 168篇 |
1974年 | 148篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
92.
93.
94.
95.
Nicola Martinelli Domenico Girelli Paolo Ferraresi Oliviero Olivieri Barbara Lunghi Franco Manzato Roberto Corrocher Francesco Bernardi 《Blood coagulation & fibrinolysis》2007,18(2):125-129
A common factor V gene haplotype, the FVR2 haplotype (FVHR2), has been associated with a reduced cofactor activity in activated protein C-mediated activated factor VIII inactivation. Our aim was to investigate the role of FVHR2 as a possible determinant of factor VIII levels in a population study. A total of 516 individuals (401 men, 115 women; mean age 58.4 +/- 10.8 years) were enrolled within the frame of a regional cardiovascular survey, characterized for factor VIII coagulant activity (FVIII:c) and factor V coagulant activity (FV:c) levels, and genotyped for factor V polymorphisms. In men without signs of overt inflammation, FVHR2 carriers had higher levels of FVIII:c than noncarriers (154 IU/dl, 95% confidence interval = 143-166 versus 142 IU/dl, 95% confidence interval = 138-147; P = 0.045) and were more represented in individuals with high (> or = 150 IU/dl) FVIII:c levels (21.2 versus 10.8%; odds ratio = 2.27, 95% confidence interval = 1.17-4.39 after adjustment for age, blood group and high-sensitivity C-reactive protein levels). In conclusion, this clinical report suggests the common FVHR2 as a possible independent determinant of FVIII:c levels. The report concomitantly addresses the relationship between factor V and factor VIII levels and supports the hypothesis of a mild prothrombotic role of FVHR2 by means of increased factor VIII levels. 相似文献
96.
97.
Shigeru Ichioka MD ; Naomi Sekiya MT ; Masahiro Shibata PhD ; Takashi Nakatsuka MD 《Wound repair and regeneration》2007,15(4):572-576
The leukocyte-endothelium interaction is known to contribute to reperfusion injury, which is considered to participate in the pathophysiology of pressure ulcers, and integrin alphaV beta3 (alphavbeta3) has been shown to mediate the processes of cellular adhesion in various types of cells. This study aims to clarify leukocyte behavior in our original microcirculatory pressure-induced reperfusion model, which can visualize the microcirculation in vivo. We also estimated the effect of alphavbeta3 integrin inhibition on the reduction of the leukocyte-endothelium interaction. Mice with dorsal skinfold chambers were divided into three groups: the baseline group (n=6), in which animals received no compression; the compression-reperfusion group (n=6), in which animals underwent 2-hour compression of the dorsal skin, followed by release, and the inhibitor-treated group (n=7), in which an alphavbeta3 inhibitor, CP4715, was administered in addition to the compression-release procedure. Staining with rhodamine 6G quantitatively visualized leukocyte behavior under the intravital fluorescent microscope. Compression-reperfusion induced a significant increase in rolling, sticking, and extravasation of the leukocytes. Treatment with the inhibitor strikingly reduced leukocyte sticking and extravasation. The present experiment has provided evidence that alphavbeta3 inhibition reduces leukocyte-endothelium interaction in our original pressure-induced reperfusion model. 相似文献
98.
99.
Salwa AlDahlawi BDS MSc ; Ameneh Eslami MD ; Lari Häkkinen DDS PhD ; Hannu S. Larjava DDS PhD 《Wound repair and regeneration》2006,14(3):289-297
The alphavbeta6 integrin is an exclusively epithelial integrin that is highly expressed during fetal development. In adult tissue, alphavbeta6 integrin is expressed during inflammation, carcinogenesis, and in wound healing. We previously reported that alphavbeta6 integrin is highly expressed in poorly healing human wounds and its over-expression is associated with chronic wounds in a mouse model. The objective of this study was to investigate the role of alphavbeta6 integrin in compromised wound healing induced by hydrocortisone treatment or aging by using young and old mice deficient in or overexpressing the beta6 integrin subunit in the epidermis. Untreated aged beta6 integrin-deficient (beta6-/-) animals showed a significant delay in wound healing when compared to their age-matched controls or younger beta6-/- mice. The most significant delay was observed at the stages where granulation tissue deposition was occurring. Hydrocortisone treatment significantly delayed wound healing in wild-type and beta6 integrin-deficient mice in comparison with the untreated controls. However, hydrocortisone treatment in beta6 integrin overexpressing animals did not cause a significant delay in wound healing. The results of this study suggest that alphavbeta6 integrin plays an important role in wound healing in animals compromised by either age or stress mimicked by hydrocortisone. 相似文献
100.
Beyond C4d: Other Complement-Related Diagnostic Approaches to Antibody-Mediated Rejection 总被引:3,自引:0,他引:3
William M. Baldwin III Edward K. Kasper rea A. Zachary Barbara A. Wasowska E. Rene Rodriguez 《American journal of transplantation》2004,4(3):311-318
Complement is a multifunctional system of receptors and regulators as well as effector molecules. Both the pathogenic and diagnostic power of complement is based on the capacity of the complement system to amplify innate and adaptive immunity. This amplification is accomplished through two strategies: (1) enzymatic reactions in the complement cascade, and (2) stimulation of leukocytes, platelets and parenchymal cells through specific receptors or receptor-independent pore formation. The mechanisms by which complement mediates and modifies nonspecific inflammation, antibody-mediated injury and T-cell responses are of particular significance to the pathogenesis of transplant rejection. Understanding the mechanisms by which complement integrates the interactions of leukocytes, platelets and parenchymal cells offers opportunities to further refine the diagnosis of rejection. 相似文献